A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood—and it can support the cells’ growth for further analysis.
The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
“If we can get these technologies to work, it will advance new cancer drugs and revolutionize the treatment of cancer patients,” said Max Wicha, M.D., Distinguished Professor of Oncology and director of the U-M Comprehensive Cancer Center and co-author of a paper on the new device, published online this week in Nature Nanotechnology.
“Circulating tumor cells will play a significant role in the early diagnosis of cancer and to help us understand if treatments are working in our cancer patients by serving as a ‘liquid’ biopsy to assess treatment responses in real time,” said co-author Dr. Diane Simeone, the Lazar J. Greenfield Professor of Surgery at the U-M Medical School and director of the Translational Oncology Program.
“Studies of circulating tumor cells will also help us understand the basic biologic mechanisms by which cancer cells metastasize or spread to distant organs—the major cause of death in cancer patients.”
Yet these cells aren’t living up to their promise in medicine because they are so difficult to separate from a blood sample, the researchers say. In the blood of early-stage cancer patients, they account for less than one in every billion cells, so catching them is tougher than finding the proverbial needle in a haystack.
“I can burn the haystack or use a huge magnet,” said Sunitha Nagrath, an assistant professor of chemical engineering, who led the research. “When it comes to circulating tumor cells, they almost look like—feel like—any other blood cell.”
On their microfluidic chip, Nagrath’s team grew dense forests of molecular chains, each equipped with an antibody to grab onto cancer cells.
Even after the cells are caught, it’s still hard to run a robust analysis on just a handful of them, the researchers say. That’s why this demonstration of highly sensitive tumor cell capture, combined with the ability to grow the cells in the same device, is so promising.
Hyeun Joong Yoon, a postdoctoral researcher in the Nagrath lab with a background in electrical engineering, was instrumental in making the microfluidic chip. He started with a silicon base and added a grid of nearly 60,000 flat gold shapes, like four-petaled flowers, each no wider than a strand of hair.
The gold flowers naturally attracted a relatively new material called graphene oxide. These sheets of carbon and oxygen, just a few atoms thick, layered themselves over the gold. This layered formation allowed the team to grow the tumor-cell-catching molecular chains so densely.
“It’s almost like each graphene has many nano-arms to capture cells,” Nagrath said.
To test the device, the team ran one-milliliter samples of blood through the chip’s thin chamber. Even when they had added just three-to-five cancer cells to the 5-10 billion blood cells, the chip was able to capture all of the cells in the sample half the time, with an average of 73 percent over 10 trials.
“That’s the highest anybody has shown in the literature for spiking such a low number of cells,” Nagrath said.
The Latest Bing News on:
Liquid biopsy
- New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomeson April 17, 2024 at 5:35 am
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the Company has ...
- Non-Invasive Liquid Biopsy Market CAGR of 15.7%, Size, Trends, Growth Status, Share, Research, and Forecast 2024 to 2032on April 16, 2024 at 10:06 pm
report_id=gc1348 Liquid biopsy has emerged as a promising non-invasive technique for detecting and monitoring various types of cancers. Unlike traditional tissue biopsies, which often involve invasive ...
- Liquid Biopsy Whole-Genome Sequencing Optimizes MRD Detection in DLBCLon April 13, 2024 at 5:00 am
Using the newly created MAESTRO-Pool tool, whole genome sequencing revealed DNA that could be used to more effectively detect minimum residual disease (MRD) in patients who have diffuse large B-cell ...
- Ovarian Cancer: Another Promising Target for Liquid Biopsyon April 11, 2024 at 5:00 pm
He called liquid biopsy "a great advance" in many oncology settings, including cancer screening because finding tumors early offers the best chance at cure. However, one of the main concerns about ...
- Study suggests liquid biopsy could detect and monitor aggressive small-cell lung canceron April 10, 2024 at 11:25 am
A new lab assay developed by researchers at Fred Hutch Cancer Center could make diagnosis and treatment of small-cell lung cancer and non-small cell lung cancer easier. The work is published in the ...
- Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Canceron April 10, 2024 at 6:24 am
A new screening test raises the possibility of catching pancreatic cancer earlier, when tumors can be removed, and patients cured.
- An exosome-based liquid biopsy shows promise for early detection of pancreatic canceron April 8, 2024 at 12:00 pm
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American ...
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
Across the United States, research teams are investigating ways to spot early cases, with many turning to blood-based liquid biopsy tests. “This term ‘liquid biopsy,’ essentially ...
- New liquid biopsy screening test for pancreatic cancer shows promise in early dataon April 8, 2024 at 8:31 am
Early data on a new blood test, which looks for bits of RNA discharged by tumors, suggests it might be able to detect pancreatic cancer at stage 1 or 2 with a sensitivity of over 90%.
- There’s still no standard test to detect pancreatic cancer early. Scientists are working to change thaton April 8, 2024 at 8:31 am
To spot breast cancer early, there are mammograms. To find colon cancer early, there are colonoscopies. But there is no standard recommended test to detect early cases of pancreatic cancer – when the ...
The Latest Google Headlines on:
Liquid biopsy
[google_news title=”” keyword=”Liquid biopsy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Diagnosing cancers
- Center offers state-of-the-art early diagnosis and treatment for lung canceron April 17, 2024 at 4:05 pm
► Get breaking news from your neighborhood delivered directly to you by downloading the new FREE WWL-TV News app now in the IOS App Store or Google Play.
- Senate President confirms cancer diagnosis, affirms reelection bidon April 17, 2024 at 3:18 pm
PROVIDENCE, R.I. (WLNE) — Senate President Dominick Ruggerio said that despite his health issues he will still seek reelection for Rhode Island’s 4th Senatorial District. A spokesperson for Ruggerio ...
- Olivia Munn Details Shock of Cancer Diagnosis After Clean Mammography 3 Months Earlieron April 17, 2024 at 2:45 pm
Olivia Munn reflected on the timeline of her shocking cancer diagnosis, which came just three months after testing negative.
- 'Shopaholic' author Sophie Kinsella diagnosed with 'aggressive' brain canceron April 17, 2024 at 10:46 am
Sophie Kinsella, author of the "Shopaholic" book series, has revealed she is battling an "aggressive" form of brain cancer.
- Shopaholic Author Sophie Kinsella Diagnosed With Brain Canceron April 17, 2024 at 10:18 am
Sophie Kinsella—best known for the beloved Shopaholic series—provided fans with a health update in which she revealed she was diagnosed with glioblastoma in 2022.
- 'Shopaholic' author Sophie Kinsella reveals brain cancer diagnosison April 17, 2024 at 10:08 am
The author of the "Shopaholic" book series that was turned into a movie is battling glioblastoma, a cancerous and aggressive brain tumor. Sophie Kinsella, 54, shared in a message on social media that ...
- Hoda Kotb reflects on going public with her breast cancer diagnosis 17 years agoon April 17, 2024 at 9:32 am
When Hoda Kotb was diagnosed with breast cancer in 2007, she found a newfound "fearless" attitude that helped her land her current role on the TODAY show.
- Olivia Munn opens up about being medically induced into menopause amid cancer diagnosison April 17, 2024 at 9:11 am
Olivia Munn has opened up about being medically induced into menopause amid her breast cancer diagnosis. Last month, the 43-year-old explained she'd been diagnosed with breast cancer the previous year ...
- Olivia Munn shares surprising tool that led to breast cancer diagnosis despite doing 'all the tests'on April 17, 2024 at 8:52 am
Olivia Munn is opening up about the series of events that led to her shocking breast cancer diagnosis and explained how one online tool ultimately helped save her life.
- Author Kinsella reveals brain cancer diagnosison April 17, 2024 at 8:02 am
Author Sophie Kinsella has revealed she has been diagnosed with an aggressive form of brain cancer. The 54-year-old, whose real name is Madeleine Sophie Wickham, is best known for writing the ...
The Latest Google Headlines on:
Diagnosing cancers
[google_news title=”” keyword=”diagnosing cancers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]